Generic Drug Application Documentation

Generic Drug Application Documentation is a regulatory documentation framework that systematically compiles scientific, clinical, and manufacturing data required to demonstrate bioequivalence and justify the approval of a generic pharmaceutical product relative to its reference listed drug.

2

Publications

43

Citations

4

Authors

2

Institutions

Publications per year

2017–2026

0

Authors

4

  1. SS
    Stephen Senn

    University of Glasgow, United Kingdom

    1 publications · 32 citations

    1

    h-index

  2. MJ
    Mark J. Gidley

    The White House, United States

    1 publications · 11 citations

    1

    h-index

  3. EO
    Enderby Outside

    University College London, United Kingdom

    1 publications · 32 citations

    1

    h-index

  4. AB
    Anthony Burgess

    University College London, United Kingdom

    1 publications · 32 citations

    1

    h-index

1–4 of 4

Institutions

2

  1. The White House

    Washington D.C., United States

    1 h-index

    1 publications

    11 citations

  2. University College London

    London, United Kingdom

    1 h-index

    3 publications

    96 citations

1–2 of 2

Venues

  1. e-Competitions Bulletin

    1 publications · 11 citations

    1

    h-index

  2. The Lancet

    1 publications · 32 citations

    1

    h-index

1–2